US Oncology Medical Lead, Lung

AstraZeneca•Gaithersburg, MD

3d•$193,281 - $289,922•Hybrid

About The Position

The US Oncology Medical Lead for Lung is based in Gaithersburg and leads US medical strategy for the lung cancer portfolio. The role connects emerging science with real-world practice and guides evidence generation and cross-functional execution from early development through launch and beyond. It partners with clinical experts, advocacy groups, and internal teams to inform treatment decisions and improve outcomes for people living with lung cancer and their families and caregivers. The position leads medical strategy, evidence initiatives, launch readiness, lifecycle activities, clinical trial support, external engagement, scientific communications, governance, and patient-centric insight gathering. It also develops team capabilities and manages budgets, vendors, and performance metrics. The role works in person an average of at least three days per week, with individual flexibility. The annual base pay range is $193,281–$289,922, with a short-term incentive bonus opportunity and eligibility to participate in an equity-based long-term incentive program. Benefits include a qualified retirement program (401(k)), paid vacation and holidays, paid leaves, and medical, prescription drug, dental, and vision coverage. Employment is at-will.

Requirements

Master’s degree in a scientific discipline; a bachelor’s degree with extensive Medical Affairs experience is also considered.
Significant Medical Affairs experience within the pharmaceutical industry.
Demonstrated project and relationship management skills, including stakeholder engagement with payers, providers, and patients.
Experience with evidence generation and clinical trial methodology.
Strong foundation in business acumen and financial management.
Expertise working in matrix team environments.

Nice To Haves

Advanced scientific or medical degree, such as a PhD, PharmD, or MD.
Understanding of the latest developments in technical, regulatory, policy, and real-world evidence generation.

Responsibilities

Own the US medical strategy for the lung cancer portfolio, aligning plans with corporate objectives and unmet patient needs and communicating priorities that drive measurable impact.
Identify evidence gaps and design and deliver interventional, non-interventional, and real-world evidence initiatives; translate insights into plans that inform clinical practice, access, and lifecycle decisions.
Lead medical launch readiness for new indications and combinations and optimize post-launch activities to influence standards of care and sustain clinical relevance.
Integrate medical perspectives across Market Access, HEOR, Compliance, Sales, and Marketing, influencing operational plans with scientific rationale and data-driven recommendations.
Guide clinical trial site and investigator engagement, feasibility inputs, and enrollment acceleration; support data interpretation for timely, high-quality study delivery and impactful readouts.
Build partnerships with scientific experts, professional societies, and patient advocacy organizations; represent Medical Affairs at congresses, advisory boards, and external forums.
Direct publication strategies, medical messaging, and congress plans; provide education and training for field medical and commercial capabilities.
Review and approve protocols, study proposals, and publications, ensuring adherence to internal governance, ethical standards, and regulatory requirements.
Capture and integrate patient and caregiver perspectives into strategies, materials, and clinical development plans.
Develop, mentor, and empower team members and foster an inclusive, high-performance culture and scalable Medical Affairs capabilities.
Manage budgets, vendors, and metrics, prioritizing activities that demonstrate medical value and efficient use of resources.